Melissa Ryan Collier, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 174 Sugartree Cir, Lipan, TX 76462 Phone: 254-631-6301 |
News Archive
The 16th annual World AIDS Day observance will be held on Tuesday, December 1, 2009 from 11:30 a.m. to 1:30 p.m. at the National AIDS Memorial Grove in Golden Gate Park. "Renewing Our Commitment" is the theme of this year's commemoration. The observance will be held, rain or shine, under the tent in The Meadow of the National AIDS Memorial.
New international guidelines published in the journal Transplantation reinforce the use of a new type of blood test to assess cytomegalovirus (CMV) risk in solid organ transplant recipients (i.e. transplant recipients). This blood test, QuantiFERON®-CMV (QF-CMV), is the first commercially-available blood test to allow physicians to monitor a person's risk of CMV disease. Most commonly used in the transplant setting, QF-CMV may predict which transplant recipients are at increased risk of CMV disease after transplant surgery.
Discovery Laboratories, Inc. today announces that the Phase 2a clinical study of aerosolized KL4 surfactant (lucinactant) in patients with cystic fibrosis (CF) has completed and the results from the study will be presented at the upcoming North American Cystic Fibrosis Conference (NACFC; October 21-23, 2010).
The interactions of the gut microbiota in children with typical diabetes autoantibodies differ from that in healthy children. The fact that these differences already exist before antibodies are detectable in the blood adds to the growing evidence that microbial DNA, the so-called microbiome, may be involved in the development of autoimmune processes.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.
› Verified 3 days ago